| Product NDC: | 13537-150 |
| Proprietary Name: | LBel |
| Non Proprietary Name: | TITANIUM DIOXIDE, OXYBENZONE, and OCTINOXATE |
| Active Ingredient(s): | .03; .03; .035 g/g; g/g; g/g & nbsp; TITANIUM DIOXIDE, OXYBENZONE, and OCTINOXATE |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 13537-150 |
| Labeler Name: | Ventura Corporation Ltd |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20120124 |
| Package NDC: | 13537-150-02 |
| Package Description: | 1 BOTTLE in 1 BOX (13537-150-02) > 12 g in 1 BOTTLE (13537-150-01) |
| NDC Code | 13537-150-02 |
| Proprietary Name | LBel |
| Package Description | 1 BOTTLE in 1 BOX (13537-150-02) > 12 g in 1 BOTTLE (13537-150-01) |
| Product NDC | 13537-150 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | TITANIUM DIOXIDE, OXYBENZONE, and OCTINOXATE |
| Dosage Form Name | POWDER |
| Route Name | TOPICAL |
| Start Marketing Date | 20120124 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Ventura Corporation Ltd |
| Substance Name | OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE |
| Strength Number | .03; .03; .035 |
| Strength Unit | g/g; g/g; g/g |
| Pharmaceutical Classes |